Recombinant glucagon: a differential biological activity

In Brazil, there is a growing demand for specialised pharmaceuticals, and the high cost of their importation results in increasing costs, reaching US$ 1.34 billion in 2012 and US$ 1.61 billion in 2013. Worldwide expenses related to drugs could reach US$ 1.3 trillion in 2018, especially due to new tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Basso, Angelina M M, Pelegrini, Patrícia B, Mulinari, Fernanda, Costa, Michelle C, Viana, Antonio B, Silva, Luciano P, Grossi-de-Sa, Maria Fatima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385203/
https://www.ncbi.nlm.nih.gov/pubmed/25852997
http://dx.doi.org/10.1186/s13568-015-0099-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385203/
https://www.ncbi.nlm.nih.gov/pubmed/25852997
http://dx.doi.org/10.1186/s13568-015-0099-2

Ejemplares similares